FIELD: biochemistry.
SUBSTANCE: described is group of inventions involving structure therapeutic agent delivery oligonucleotide polymer nano particle oligonucleotide delivery, containing above therapeutic agent-polymer, conjugate anti-sense oligonucleotide (ASO)-polymer for delivery of anti-sense oligonucleotide polymer, nano particle for delivery of anti-sense oligonucleotide containing above conjugate ASO-polymer and method of conjugate ASO-polymer producing.
EFFECT: invention extends range of products, ensuring delivery of oligo-RNA in organism.
27 cl, 21 dwg, 12 ex
Authors
Dates
2016-10-10—Published
2012-12-14—Filed